Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
CA$0.02 - CA$0.05
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$16.37M |
EV | CA$20.67M |
Shares Outstanding | 567.52M |
Beta | 0.71 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2020E | - |
P/Revenue 2020E | - |
Revenue | -54.00% |
EPS | 18.10% |
Operating Cash Flow | 8.90% |
Free Cash Flow | 11.70% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2020E | - |
Net Profit Margin 2020E | - |
ROE 2020E | - |
ROCE 2019 | - |
DPS 2020E | - |
Payout Ratio 2020E | - |
Div. Yield 2020E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
PreveCeutical Medical Inc.
PREV
Sector
Healthcare
Industry
Biotechnology
CEO
Van Deventer, Stephen
Employees
Website
www.preveceutical.comIPO Date
2017-01-11
Headquarters
5428 Marine Drive, Suite 2500, West Vancouver, British Columbia, V7W 2R2, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved